☰

Matthew B. Lawrenz, Ph.D. - Publications

Affiliations: 
2003 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Microbiology Biology, Immunology, Pathology
Tree Info Similar researchers PubMed Report error

34/52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2025 Sheneman KR, Cummins TD, Merchant ML, Hood JL, Uriarte SM, Lawrenz MB. Yersinia pestis Actively Inhibits the Production of Extracellular Vesicles by Human Neutrophils. Journal of Extracellular Vesicles. 14: e70074. PMID 40240908 DOI: 10.1002/jev2.70074  0.337
2024 Sheneman KR, Cummins TD, Merchant ML, Hood JL, Uriarte SM, Lawrenz MB. actively inhibits the production of extracellular vesicles by human neutrophils. Biorxiv : the Preprint Server For Biology. PMID 39763979 DOI: 10.1101/2024.12.20.629761  0.336
2024 Brady A, Mora Martinez LC, Hammond B, Whitefoot-Keliin KM, Haribabu B, Uriarte SM, Lawrenz MB. Distinct mechanisms of type 3 secretion system recognition control LTB4 synthesis in neutrophils and macrophages. Plos Pathogens. 20: e1012651. PMID 39423229 DOI: 10.1371/journal.ppat.1012651  0.301
2024 Brady A, Sheneman KR, Pulsifer AR, Price SL, Garrison TM, Maddipati KR, Bodduluri SR, Pan J, Boyd NL, Zheng JJ, Rai SN, Hellmann J, Haribabu B, Uriarte SM, Lawrenz MB. Type 3 secretion system induced leukotriene B4 synthesis by leukocytes is actively inhibited by Yersinia pestis to evade early immune recognition. Plos Pathogens. 20: e1011280. PMID 38271464 DOI: 10.1371/journal.ppat.1011280  0.329
2020 Lei C, Mu J, Teng Y, He L, Xu F, Zhang X, Sundaram K, Kumar A, Sriwastva MK, Lawrenz MB, Zhang L, Yan J, Feng W, McClain CJ, Zhang X, et al. Lemon Exosome-like Nanoparticles-Manipulated Probiotics Protect Mice from   Infection. Iscience. 23: 101571. PMID 33083738 DOI: 10.1016/J.Isci.2020.101571  0.341
2019 Pulsifer AR, Vashishta A, Reeves SA, Wolfe JK, Palace SG, Proulx MK, Goguen J, Bodduluri SR, Haribabu B, Uriarte SM, Lawrenz MB. Redundant and cooperative roles for Yop effectors in the inhibition of human neutrophil exocytic responses revealed by gain-of-function approach. Infection and Immunity. PMID 31871100 DOI: 10.1128/Iai.00909-19  0.383
2019 Pulsifer AR, VanCleave TT, Lawrenz MB. Intracellular Assays to Monitor Survival and Growth of Yersinia pestis Within Macrophages. Methods in Molecular Biology (Clifton, N.J.). 2010: 181-196. PMID 31177439 DOI: 10.1007/978-1-4939-9541-7_13  0.436
2019 Will WR, Brzovic P, Le Trong I, Stenkamp RE, Lawrenz MB, Karlinsey JE, Navarre WW, Main-Hester K, Miller VL, Libby SJ, Fang FC. The Evolution of SlyA/RovA Transcription Factors from Repressors to Countersilencers in . Mbio. 10. PMID 30837332 DOI: 10.1128/Mbio.00009-19  0.509
2018 Hegde B, Bodduluri SR, Satpathy SR, Alghsham RS, Jala VR, Uriarte SM, Chung DH, Lawrenz MB, Haribabu B. Inflammasome-Independent Leukotriene BProduction Drives Crystalline Silica-Induced Sterile Inflammation. Journal of Immunology (Baltimore, Md. : 1950). PMID 29610142 DOI: 10.4049/Jimmunol.1701504  0.303
2018 Connor MG, Pulsifer AR, Chung D, Rouchka EC, Ceresa BK, Lawrenz MB. Targets the Host Endosome Recycling Pathway during the Biogenesis of the-Containing Vacuole To Avoid Killing by Macrophages. Mbio. 9. PMID 29463656 DOI: 10.1128/Mbio.01800-17  0.697
2017 VanCleave TT, Pulsifer AR, Connor MG, Warawa JM, Lawrenz MB. Impact of Gentamicin Concentration and Exposure Time on Intracellular Yersinia pestis. Frontiers in Cellular and Infection Microbiology. 7: 505. PMID 29312891 DOI: 10.3389/Fcimb.2017.00505  0.684
2017 Bobrov AG, Kirillina O, Fosso MY, Fetherston JD, Miller MC, VanCleave TT, Burlison JA, Arnold WK, Lawrenz MB, Garneau-Tsodikova S, Perry RD. Zinc transporters YbtX and ZnuABC are required for the virulence of Yersinia pestis in bubonic and pneumonic plague in mice. Metallomics : Integrated Biometal Science. PMID 28540946 DOI: 10.1039/C7Mt00126F  0.355
2017 Price C, Merchant M, Jones S, Best A, Von Dwingelo J, Lawrenz MB, Alam N, Schueler-Furman O, Kwaik YA. Host FIH-Mediated Asparaginyl Hydroxylation of Translocated Legionella pneumophila Effectors. Frontiers in Cellular and Infection Microbiology. 7: 54. PMID 28321389 DOI: 10.3389/Fcimb.2017.00054  0.323
2017 Lawrenz MB, denDekker AE, Cramer DE, Gabbard JD, Lafoe KM, Pfeffer TL, Sotsky JB, Vanover CD, Ellis-Grosse EJ, Warawa JM. ZTI-01 Treatment Improves Survival of Animals Infected with Multidrug Resistant Pseudomonas aeruginosa Open Forum Infectious Diseases. 4: S474-S474. DOI: 10.1093/Ofid/Ofx163.1213  0.342
2016 Payne JN, Waghwani HK, Connor MG, Hamilton W, Tockstein S, Moolani H, Chavda F, Badwaik V, Lawrenz MB, Dakshinamurthy R. Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity. Frontiers in Microbiology. 7: 607. PMID 27330535 DOI: 10.3389/Fmicb.2016.00607  0.648
2015 Connor MG, Pulsifer AR, Price CT, Abu Kwaik Y, Lawrenz MB. Yersinia pestis Requires Host Rab1b for Survival in Macrophages. Plos Pathogens. 11: e1005241. PMID 26495854 DOI: 10.1371/Journal.Ppat.1005241  0.697
2015 Lawrenz MB, Biller AE, Cramer DE, Kraenzle JL, Sotsky JB, Vanover CD, Yoder-Himes DR, Pollard A, Warawa JM. Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing. Pathogens and Disease. 73. PMID 25857733 DOI: 10.1093/Femspd/Ftv025  0.343
2014 Warawa JM, Lawrenz MB. Bioluminescent imaging of bacteria during mouse infection. Methods in Molecular Biology (Clifton, N.J.). 1098: 169-81. PMID 24166377 DOI: 10.1007/978-1-62703-718-1_14  0.366
2013 Lawrenz MB, Pennington J, Miller VL. Acquisition of omptin reveals cryptic virulence function of autotransporter YapE in Yersinia pestis. Molecular Microbiology. 89: 276-87. PMID 23701256 DOI: 10.1111/Mmi.12273  0.527
2012 Sun Y, Connor MG, Pennington JM, Lawrenz MB. Development of bioluminescent bioreporters for in vitro and in vivo tracking of Yersinia pestis. Plos One. 7: e47123. PMID 23071730 DOI: 10.1371/Journal.Pone.0047123  0.672
2011 Lenz JD, Lawrenz MB, Cotter DG, Lane MC, Gonzalez RJ, Palacios M, Miller VL. Expression during host infection and localization of Yersinia pestis autotransporter proteins. Journal of Bacteriology. 193: 5936-49. PMID 21873491 DOI: 10.1128/Jb.05877-11  0.545
2011 Weening EH, Cathelyn JS, Kaufman G, Lawrenz MB, Price P, Goldman WE, Miller VL. The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background. Infection and Immunity. 79: 644-52. PMID 21115720 DOI: 10.1128/Iai.00981-10  0.538
2010 Lawrenz MB. Model systems to study plague pathogenesis and develop new therapeutics. Frontiers in Microbiology. 1: 119. PMID 21687720 DOI: 10.3389/Fmicb.2010.00119  0.31
2009 Lawrenz MB, Lenz JD, Miller VL. A novel autotransporter adhesin is required for efficient colonization during bubonic plague. Infection and Immunity. 77: 317-26. PMID 18936182 DOI: 10.1128/Iai.01206-08  0.563
2008 Felek S, Lawrenz MB, Krukonis ES. The Yersinia pestis autotransporter YapC mediates host cell binding, autoaggregation and biofilm formation. Microbiology (Reading, England). 154: 1802-12. PMID 18524935 DOI: 10.1099/Mic.0.2007/010918-0  0.402
2007 Lawrenz MB, Miller VL. Comparative analysis of the regulation of rovA from the pathogenic yersiniae. Journal of Bacteriology. 189: 5963-75. PMID 17573476 DOI: 10.1128/Jb.00528-07  0.447
2004 Lawrenz MB, Wooten RM, Norris SJ. Effects of vlsE complementation on the infectivity of Borrelia burgdorferi lacking the linear plasmid lp28-1. Infection and Immunity. 72: 6577-85. PMID 15501789 DOI: 10.1128/Iai.72.11.6577-6585.2004  0.68
2004 Ellison DW, Lawrenz MB, Miller VL. Invasin and beyond: regulation of Yersinia virulence by RovA. Trends in Microbiology. 12: 296-300. PMID 15165608 DOI: 10.1016/J.Tim.2004.04.006  0.503
2003 Lawrenz MB, Wooten RM, Zachary JF, Drouin SM, Weis JJ, Wetsel RA, Norris SJ. Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infection and Immunity. 71: 4432-40. PMID 12874322 DOI: 10.1128/Iai.71.8.4432-4440.2003  0.56
2003 Purser JE, Lawrenz MB, Caimano MJ, Howell JK, Radolf JD, Norris SJ. A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Molecular Microbiology. 48: 753-64. PMID 12694619 DOI: 10.1046/J.1365-2958.2003.03452.X  0.69
2002 Lawrenz MB, Kawabata H, Purser JE, Norris SJ. Decreased electroporation efficiency in Borrelia burgdorferi containing linear plasmids lp25 and lp56: impact on transformation of infectious B. burgdorferi. Infection and Immunity. 70: 4798-804. PMID 12183522 DOI: 10.1128/Iai.70.9.4798-4804.2002  0.661
2002 Magnarelli LA, Lawrenz M, Norris SJ, Fikrig E. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. Journal of Medical Microbiology. 51: 649-55. PMID 12171295 DOI: 10.1099/0022-1317-51-8-649  0.528
2002 Eicken C, Sharma V, Klabunde T, Lawrenz MB, Hardham JM, Norris SJ, Sacchettini JC. Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi. The Journal of Biological Chemistry. 277: 21691-6. PMID 11923306 DOI: 10.1074/Jbc.M201547200  0.482
1999 Lawrenz MB, Hardham JM, Owens RT, Nowakowski J, Steere AC, Wormser GP, Norris SJ. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. Journal of Clinical Microbiology. 37: 3997-4004. PMID 10565921 DOI: 10.1128/Jcm.37.12.3997-4004.1999  0.516
Low-probability matches (unlikely to be authored by this person)
2024 Brady A, Mora-Martinez LC, Hammond B, Haribabu B, Uriarte SM, Lawrenz MB. Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB Synthesis in Neutrophils versus Macrophages. Biorxiv : the Preprint Server For Biology. PMID 39005373 DOI: 10.1101/2024.07.01.601466  0.291
2021 Price SL, Vadyvaloo V, DeMarco JK, Brady A, Gray PA, Kehl-Fie TE, Garneau-Tsodikova S, Perry RD, Lawrenz MB. Yersiniabactin contributes to overcoming zinc restriction during infection of mammalian and insect hosts. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34716262 DOI: 10.1073/pnas.2104073118  0.283
2014 Lawrenz MB, Fodah RA, Gutierrez MG, Warawa J. Intubation-mediated intratracheal (IMIT) instillation: a noninvasive, lung-specific delivery system. Journal of Visualized Experiments : Jove. e52261. PMID 25490457 DOI: 10.3791/52261  0.279
2020 DiNubile MJ, Levinson SL, Stossel TP, Lawrenz MB, Warawa JM. Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pneumonia. Open Forum Infectious Diseases. 7: ofaa236. PMID 32766380 DOI: 10.1093/Ofid/Ofaa236  0.265
2023 Price SL, Thibault D, Garrison TM, Brady A, Guo H, Kehl-Fie TE, Garneau-Tsodikova S, Perry RD, van Opijnen T, Lawrenz MB. Droplet Tn-Seq identifies the primary secretion mechanism for yersiniabactin in Yersinia pestis. Embo Reports. e57369. PMID 37501563 DOI: 10.15252/embr.202357369  0.248
2023 Price SL, Oakes RS, Gonzalez RJ, Edwards C, Brady A, DeMarco JK, von Andrian UH, Jewell CM, Lawrenz MB. Microneedle array delivery of recapitulates bubonic plague. Iscience. 27: 108600. PMID 38179062 DOI: 10.1016/j.isci.2023.108600  0.24
2022 Warawa JM, Duan X, Anderson CD, Sotsky JB, Cramer DE, Pfeffer TL, Guo H, Adcock S, Lepak AJ, Andes DR, Slone SA, Stromberg AJ, Gabbard JD, Severson WE, Lawrenz MB. Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains. Microbiology Spectrum. e0269322. PMID 36094219 DOI: 10.1128/spectrum.02693-22  0.239
2014 Dinc G, Pennington JM, Yolcu ES, Lawrenz MB, Shirwan H. Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant. Vaccine. 32: 5035-40. PMID 25045812 DOI: 10.1016/J.Vaccine.2014.07.015  0.225
2019 Bowen W, Batra L, Pulsifer AR, Yolcu ES, Lawrenz MB, Shirwan H. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague. Vaccine. PMID 31416643 DOI: 10.1016/J.Vaccine.2019.07.103  0.22
2021 Duplessis C, Warawa JM, Lawrenz MB, Henry M, Biswas B. Successful Intratracheal Treatment of Phage and Antibiotic Combination Therapy of a Multi-Drug Resistant Murine Model. Antibiotics (Basel, Switzerland). 10. PMID 34438996 DOI: 10.3390/antibiotics10080946  0.198
2022 Kumar A, Yang T, Chakravorty S, Majumdar A, Nairn BM, Six DA, Marcondes Dos Santos N, Price SL, Lawrenz MB, Actis LA, Marques M, Russo TA, Newton SM, Klebba PE. Fluorescent Sensors of Siderophores produced by Bacterial Pathogens. The Journal of Biological Chemistry. 101651. PMID 35101443 DOI: 10.1016/j.jbc.2022.101651  0.184
2021 Behnsen J, Zhi H, Aron AT, Subramanian V, Santus W, Lee MH, Gerner RR, Petras D, Liu JZ, Green KD, Price SL, Camacho J, Hillman H, Tjokrosurjo J, Montaldo NP, ... ... Lawrenz MB, et al. Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut. Nature Communications. 12: 7016. PMID 34853318 DOI: 10.1038/s41467-021-27297-2  0.168
2024 Brady A, Garrison TM, Ernst RK, Rasko DA, Lawrenz MB. Draft genome sequences of evolutionary distant species representatives. Microbiology Resource Announcements. e0099624. PMID 39655931 DOI: 10.1128/mra.00996-24  0.163
2024 Brady A, Tomaszewski M, Garrison TM, Lawrenz MB. Approaches for the Inactivation of . Applied Biosafety : Journal of the American Biological Safety Association. 29: 221-231. PMID 39735406 DOI: 10.1089/apb.2023.0022  0.15
2017 Radka CD, DeLucas LJ, Wilson LS, Lawrenz MB, Perry RD, Aller SG. Crystal structure of Yersinia pestis virulence factor YfeA reveals two polyspecific metal-binding sites. Acta Crystallographica. Section D, Structural Biology. 73: 557-572. PMID 28695856 DOI: 10.1107/S2059798317006349  0.116
2014 Shah M, Badwaik V, Kherde Y, Waghwani HK, Modi T, Aguilar ZP, Rodgers H, Hamilton W, Marutharaj T, Webb C, Lawrenz MB, Dakshinamurthy R. Gold nanoparticles: various methods of synthesis and antibacterial applications. Frontiers in Bioscience (Landmark Edition). 19: 1320-44. PMID 24896353 DOI: 10.2741/4284  0.114
2020 Byrne JM, Waack U, Weinstein EA, Joshi A, Shurland SM, Iarikov D, Bulitta JB, Diep BA, Guina T, Hope WW, Lawrenz MB, Lepak AJ, Luna BM, Miesel L, Phipps AJ, et al. FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development. Antimicrobial Agents and Chemotherapy. PMID 33106262 DOI: 10.1128/AAC.01983-20  0.083
2015 Hamilton W, Modi T, Waghwani HK, Tockstein S, Payne J, Filani O, Badwaik V, Shah M, Webb C, Lawrenz MB, Dakshinamurthy R. Nanotechnology's Impact on Medicinal Chemistry. Mini Reviews in Medicinal Chemistry. PMID 25963566  0.05
Hide low-probability matches.